Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2005
10/27/2005US20050239140 Solution phase biopanning method using engineered decoy proteins
10/27/2005US20050239139 Selectively binding and/or detecting an aggregating abnormal form of a prion protein in the presence of non-aggregating normal form of the protein; brain disorder
10/27/2005US20050239138 Use of cardiac hormones to assess risk of cardiovascular complication from volume overload
10/27/2005US20050239137 Assay for carbohydrate-free transferrin
10/27/2005US20050239136 Risk markers for cardiovacular disease
10/27/2005US20050239135 Compositions, methods and kits for biarsenical fluorophore labeling
10/27/2005US20050239134 Combinatorial selection of phosphorothioate single-stranded DNA aptamers for TGF-beta-1 protein
10/27/2005US20050239133 Methods to identify true antagonists and inverse agonists of the cannabinoid receptor
10/27/2005US20050239132 Method and device for determining a concentration of ligands in an analysed sample
10/27/2005US20050239125 Methods for genotype screening
10/27/2005US20050239122 Novel tumor antigen useful in diagnosis and therapy of prostate and colon cancer
10/27/2005US20050239121 Non-aggregating non-quenching oligomers comprising nucleotide analogs; methods of synthesis and use thereof
10/27/2005US20050239120 Bio molecular detection apparatus and method thereof
10/27/2005US20050239119 PCR amplification reaction apparatus and method for PCR amplification reaction using apparatus
10/27/2005US20050239117 Biochip measuring method and biochip measuring apparatus
10/27/2005US20050239116 improved sensitivity, reproducibility and/or lower detection limits; Nucleic acid analytes can be co-amplified with known amounts of corresponding competitive templates; non-nucleic acid analytes can be coupled to nucleic acid tags and tags can be co-amplified with known amounts of competitive templates
10/27/2005US20050239115 Methods and devices for microarray image
10/27/2005US20050239114 Methods and devices for microarray image analysis
10/27/2005US20050239113 Methods and devices for microarray image
10/27/2005US20050239112 Methods and processes for attaching compounds to matrices
10/27/2005US20050239111 Method for screening compounds using consensus selection and multiple descriptor sets
10/27/2005US20050239110 Method of diagnosing depression
10/27/2005US20050239108 Immuno-PCR method for the detection of a biomolecule in a test sample
10/27/2005US20050239107 Trapped photochromes and thermochromes and uses for chromogenic detection, including detection of airborne contaminants
10/27/2005US20050239103 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
10/27/2005US20050239102 Libraries of short nucleotide oligomers to bind the tertiary or globular structure of nucleic acids; kit identifies non-canonical binding oligomers; binding forces independent of Watson-Crick, Hoogstein base-pairing rules; Hepatitis C virus, Human Immnuodeficiency virus, Herpes virus
10/27/2005US20050239099 27 human secreted proteins
10/27/2005US20050239095 Use of Pin1 inhibitors for treatment of cancer
10/27/2005US20050239084 Probes and methods for detection of nucleic acids
10/27/2005US20050239076 Analysis system
10/27/2005US20050239073 Fluorescent entity comprising a fluorophore covalently attached to at least one oligonucleotide and comprising at least one functional group, and uses thereof
10/27/2005US20050239072 Device and methods for concentrating prion protein isoforms
10/27/2005US20050239069 which influence haemoglobin formation in neuronal, myocardial and/or skeletomuscular cells; gene therapy
10/27/2005US20050239068 Method for isolating nucleic acids and protein from a single sample
10/27/2005US20050239066 Support for ligand immobilization
10/27/2005US20050239064 Methods and compositions based on protein interactions with mastermind
10/27/2005US20050239062 diagnosing Alzheimer's disease by measuring abundance of low-density lipoprotein receptor related protein-1 (LRP-1), abundance of transcripts thereof, or LRP-1 receptor activity and comparing with an age-matched control
10/27/2005US20050239058 Method for the detection, identification, enumeration and confirmation of virally infected cells and other epitopically defined cells in whole blood
10/27/2005US20050239056 Methods and kits for predicting an infectious disease state
10/27/2005US20050239054 Drug screening compounds having esterified phosphonate or carboxyl groups with novel enzyme GS-7340 Ester Hydrolase and identifying the compound as a suitable prodrug by the formation of a phosphonic acid or carboxylic acid; candidate compounds
10/27/2005US20050239053 New mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistance
10/27/2005US20050239051 Use of isogenic human cancer cells for high-throughput screening and drug discovery
10/27/2005US20050239050 Use of MDCK cell line to predict corneal penetration of drugs
10/27/2005US20050239048 Method and apparatus for enhancing biological photon receptors using plasmon resonance
10/27/2005US20050239047 Methods and devices for determining a cell characteristic, and applications employing the same
10/27/2005US20050239046 Method and apparatus for measuring changes in cell volume
10/27/2005US20050239043 Subtilisin carlsberg proteins with reduced immunogenicity
10/27/2005US20050238793 Methods of assessing characteristics of fibrous substrates and treating fibrous substrates
10/27/2005US20050238734 Detection of nitrosylated proteins
10/27/2005US20050238685 Method of binding a compound to a surface
10/27/2005US20050238652 Human lung adenocarcinoma-related monoclonal antibody and antigen and immunaossay method which uses the same
10/27/2005US20050238620 Suppressing fibrosis in a mammal having a fibrosing disease by administering a Serum Amyloid P (SAP) protein; treatment of diseases such as scleroderma, pulmonary fibrosis and asthma
10/27/2005US20050238590 Incorporation of exogenous lactic bacteria into the oral microflora
10/27/2005US20050238582 Administering a conjugate of a a cell and a light-generating moiety; and measuring photon emission through an opaque tissue of said mammalian subject from the light-generating moiety; used for tracking the progression of infection
10/27/2005US20050238581 Dynamic hepatic recycling glucose tolerance test
10/27/2005US20050238580 Use of 4-galactosyl-xylose in humans for the in vivo evaluation of intestinal lactase as a non-invasive diagnostic test of the deficiency of said enzyme
10/27/2005US20050238579 Human g protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure
10/27/2005US20050238541 Retaining clip for reagent test slides
10/27/2005US20050238536 Device and method for measuring glycosaminoglycans in body fluids
10/27/2005US20050238535 Rapid assay, method and system for detecting biowarfare agents
10/27/2005US20050238534 Apparatus and methods for efficient processing of biological samples on slides
10/27/2005US20050238428 System and method for field testing a tack coat layer
10/27/2005US20050236330 Method for determining concentration; a dialyser
10/27/2005US20050235763 Dust testing facility for motor vehicles
10/27/2005US20050235757 Sampling device and method for measuring fluid flow and solute mass transport
10/27/2005US20050235738 System and method for detecting and measuring liquid carry over in a gas stream
10/27/2005US20050235736 Device for determining the fineness of mineral fibers
10/27/2005US20050235735 Micro-structured gas sensor with control of gas sensitive properties by application of an electric field
10/27/2005DE19964269B4 Verfahren zur Detektion des Proliferationspotentials von Zellen A process for the detection of the proliferation potential of cells
10/27/2005DE19537846B4 Fibre flocking coarse cleaning appts. - has airstream to carry flocking through channel with optical sensor system and separator for detected foreign matter
10/27/2005DE102005010544A1 Dissolution sample transfer device for use in high performance liquid chromatography analysis, comprises needles movable on movement of a delivery head so that their tips are positioned above/in vials
10/27/2005DE102004047963A1 Micro-fluidic chip for high-throughput screening and high-throughput assay, comprises well for isolating specimen, specimen-isolating device, opening and closing device, inlet and outlet, and reagent-injecting passage
10/27/2005DE102004017750A1 Analyse-Array mit heizbaren Elektroden und Verfahren für die chemische und biochemische Analytik Analysis array with heatable electrodes and methods for chemical and biochemical analysis
10/27/2005DE102004017586A1 Gassonde mit beschichteter Schutzeinrichtung Gas sensor with a coated guard
10/27/2005DE102004016957A1 Messvorrichtung zum Messen des Zustands von Ölen oder Fetten Measuring device for measuring the state of oils or fats
10/27/2005DE102004016955A1 Messvorrichtung zur Messung des Zustandes von Ölen oder Fetten (Temperatursensor) Measuring device for measuring the state of oils or fats (temperature sensor)
10/27/2005DE102004012524A1 Verfahren zur Bestimmung wahrer Molekülmassen von Konstituenten biologischer Proben Method for the determination of true molecular masses of the constituents of biological samples
10/27/2005DE102004009870B3 Verfahren und Vorrichtung zur Charakterisierung von OSI-Material Method and device for characterization of the OSI material
10/27/2005DE10141694B4 Verfahren und Vorrichtung zur Messung der Viskosität einer Flüssigkeit Method and apparatus for measuring the viscosity of a liquid
10/27/2005CA2848463A1 Gene expression markers for predicting response to chemotherapy
10/27/2005CA2776927A1 Phosphorylcholine conjugates and corresponding antibodies
10/27/2005CA2770521A1 Tape stripping methods for analysis of skin disease and pathological skin state
10/27/2005CA2606138A1 Prostate cancer diagnosis and treatment
10/27/2005CA2563726A1 Compounds, mesostructured porous hybrid organic-inorganic materials and sensors which can be used for the detection or quantitative determination of halogenated gaseous compounds
10/27/2005CA2563413A1 Method and system for drug screening
10/27/2005CA2563404A1 Non-covalent immobilization of indicator molecules
10/27/2005CA2563390A1 Compounds that block the c5a receptor and their use in therapy
10/27/2005CA2563333A1 Orphan receptor tyrosine kinase as a target in breast cancer
10/27/2005CA2563332A1 Therapeutic uspa1-derived peptides
10/27/2005CA2563295A1 Antibodies to erythropoietin receptor and uses thereof
10/27/2005CA2563078A1 Sytems and methods for improving livestock production
10/27/2005CA2563026A1 Method for analyzing n-terminal protein adducts
10/27/2005CA2562892A1 Bob-1 specific t cells and methods to use
10/27/2005CA2562881A1 Novel monkey gpr103 and monkey qrfp and method of evaluating compound by using gpr103
10/27/2005CA2562839A1 Method for assessment of cytotoxic t lymphocyte activity
10/27/2005CA2562838A1 Smart combinatorial operando spectroscopy catalytic system
10/27/2005CA2562835A1 A method for monitoring the progress of cancer
10/27/2005CA2562564A1 Protein-protein interactions for pharmacological profiling
10/27/2005CA2562550A1 Phosphorylcholine conjugates and corresponding antibodies
10/27/2005CA2562520A1 Dual-transfected cells lines as in vitro screening tools for pharmaceutical compound profiling: a model for heptobiliary elimination
1 ... 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 ... 3937